2Seventy Bio Inc
NASDAQ:TSVT
Income Statement
Earnings Waterfall
2Seventy Bio Inc
Revenue
|
100.4m
USD
|
Cost of Revenue
|
-16.9m
USD
|
Gross Profit
|
83.5m
USD
|
Operating Expenses
|
-300.4m
USD
|
Operating Income
|
-216.9m
USD
|
Other Expenses
|
-632k
USD
|
Net Income
|
-217.6m
USD
|
Income Statement
2Seventy Bio Inc
Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue |
57
N/A
|
51
-10%
|
92
+78%
|
125
+36%
|
147
+18%
|
146
-1%
|
100
-31%
|
|
Gross Profit | ||||||||
Cost of Revenue |
(5)
|
(13)
|
(17)
|
(31)
|
(31)
|
(29)
|
(17)
|
|
Gross Profit |
52
N/A
|
39
-25%
|
75
+93%
|
94
+25%
|
116
+24%
|
117
+1%
|
83
-29%
|
|
Operating Income | ||||||||
Operating Expenses |
(343)
|
(334)
|
(328)
|
(313)
|
(311)
|
(301)
|
(300)
|
|
Selling, General & Administrative |
(89)
|
(85)
|
(80)
|
(76)
|
(79)
|
(72)
|
(69)
|
|
Research & Development |
(254)
|
(248)
|
(249)
|
(237)
|
(232)
|
(229)
|
(231)
|
|
Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Operating Income |
(292)
N/A
|
(295)
-1%
|
(254)
+14%
|
(220)
+13%
|
(195)
+11%
|
(184)
+6%
|
(217)
-18%
|
|
Pre-Tax Income | ||||||||
Interest Income Expense |
0
|
2
|
3
|
5
|
8
|
10
|
12
|
|
Non-Reccuring Items |
(10)
|
(10)
|
(10)
|
(4)
|
0
|
(21)
|
(21)
|
|
Total Other Income |
17
|
11
|
6
|
4
|
7
|
11
|
8
|
|
Pre-Tax Income |
(284)
N/A
|
(292)
-3%
|
(254)
+13%
|
(215)
+15%
|
(180)
+16%
|
(184)
-2%
|
(218)
-18%
|
|
Net Income | ||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(284)
|
(292)
|
(254)
|
(215)
|
(180)
|
(184)
|
(218)
|
|
Net Income (Common) |
(284)
N/A
|
(292)
-3%
|
(254)
+13%
|
(215)
+15%
|
(180)
+16%
|
(184)
-2%
|
(218)
-18%
|
|
EPS (Diluted) |
-7.4
N/A
|
-7.47
-1%
|
-7.13
+5%
|
-4.95
+31%
|
-3.53
+29%
|
-3.59
-2%
|
-4.42
-23%
|